Oral propranolol as a new treatment for facial infantile hemangioma: case report
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Arquivos brasileiros de oftalmologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000300012 |
Resumo: | Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects. |
id |
CBO-2_744def1af9695b7a5613dc77113ff6ac |
---|---|
oai_identifier_str |
oai:scielo:S0004-27492011000300012 |
network_acronym_str |
CBO-2 |
network_name_str |
Arquivos brasileiros de oftalmologia (Online) |
repository_id_str |
|
spelling |
Oral propranolol as a new treatment for facial infantile hemangioma: case reportHemangiomaHemangioma, capillary/therapyPropranolol/therapeutic useCase reportsInfant, newbornHemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.Conselho Brasileiro de Oftalmologia2011-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000300012Arquivos Brasileiros de Oftalmologia v.74 n.3 2011reponame:Arquivos brasileiros de oftalmologia (Online)instname:Conselho Brasileiro de Oftalmologia (CBO)instacron:CBO10.1590/S0004-27492011000300012info:eu-repo/semantics/openAccessFerreira,Rosane da CruzWolff,Francisco Romeu LocatelliMörschbächer,Ricardoeng2011-09-02T00:00:00Zoai:scielo:S0004-27492011000300012Revistahttp://aboonline.org.br/https://old.scielo.br/oai/scielo-oai.phpaboonline@cbo.com.br||abo@cbo.com.br1678-29250004-2749opendoar:2011-09-02T00:00Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO)false |
dc.title.none.fl_str_mv |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
title |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
spellingShingle |
Oral propranolol as a new treatment for facial infantile hemangioma: case report Ferreira,Rosane da Cruz Hemangioma Hemangioma, capillary/therapy Propranolol/therapeutic use Case reports Infant, newborn |
title_short |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
title_full |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
title_fullStr |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
title_full_unstemmed |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
title_sort |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
author |
Ferreira,Rosane da Cruz |
author_facet |
Ferreira,Rosane da Cruz Wolff,Francisco Romeu Locatelli Mörschbächer,Ricardo |
author_role |
author |
author2 |
Wolff,Francisco Romeu Locatelli Mörschbächer,Ricardo |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Ferreira,Rosane da Cruz Wolff,Francisco Romeu Locatelli Mörschbächer,Ricardo |
dc.subject.por.fl_str_mv |
Hemangioma Hemangioma, capillary/therapy Propranolol/therapeutic use Case reports Infant, newborn |
topic |
Hemangioma Hemangioma, capillary/therapy Propranolol/therapeutic use Case reports Infant, newborn |
description |
Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000300012 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000300012 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0004-27492011000300012 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Conselho Brasileiro de Oftalmologia |
publisher.none.fl_str_mv |
Conselho Brasileiro de Oftalmologia |
dc.source.none.fl_str_mv |
Arquivos Brasileiros de Oftalmologia v.74 n.3 2011 reponame:Arquivos brasileiros de oftalmologia (Online) instname:Conselho Brasileiro de Oftalmologia (CBO) instacron:CBO |
instname_str |
Conselho Brasileiro de Oftalmologia (CBO) |
instacron_str |
CBO |
institution |
CBO |
reponame_str |
Arquivos brasileiros de oftalmologia (Online) |
collection |
Arquivos brasileiros de oftalmologia (Online) |
repository.name.fl_str_mv |
Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO) |
repository.mail.fl_str_mv |
aboonline@cbo.com.br||abo@cbo.com.br |
_version_ |
1754209026851209216 |